Get the full picture
Sign in to uncover key details.
Syntax Bio
Blood & Organ Banks · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 N Aberdeen St Fl 9, Chicago, Illinoi...Website
www.syntax-bio.comRevenue
<$5 MillionIndustry
About Syntax Bio
Syntax Bio is a Chicago, IL-based preclinical-stage biotechnology company. Co-founded by Ryan Clarke, PhD, and Professor Brad Merrill, PhD, from the University of Illinois at Chicago, Syntax Bio is a preclinical-stage biotechnology company that is focused on generating therapeutic-grade cells from stem cells leveraging its novel Cellgorithm platform technology. Its Cellgorithm platform mimics human developmental processes at the epigenetic level, using a modified CRISPR system to regulate endogenous genes in an automatic and temporally controlled manner.Explore more
Syntax Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Syntax Bio
Sign Up For FreeTo access detailed company insights
Syntax Bio is a Chicago, IL-based preclinical-stage biotechnology company. Co-founded by Ryan Clarke, PhD, and Professor Brad Merrill, PhD, from the University of Illinois at Chicago, Syntax Bio is a preclinical-stage biotechnology company that is focused on generating therapeutic-grade cells from stem cells leveraging its novel Cellgorithm platfor... Read More
